Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | INCAGN02390 |
Trade Name | |
Synonyms | INCAGN 02390|INCAGN-02390 |
Drug Descriptions |
INCAGN02390 is an antibody that targets the immune inhibitory receptor TIM-3, potentially resulting in decreased tumor growth when combined with other immune checkpoint inhibitors (Cancer Res July 1 2018 (78) (13 Supplement) 3825). |
DrugClasses | TIM-3 Antibody 9 |
CAS Registry Number | NA |
NCIT ID | C162625 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
INCAGN02385 + INCAGN02390 | INCAGN02385 INCAGN02390 | 0 | 1 |
INCAGN02385 + INCAGN02390 + Retifanlimab | INCAGN02385 INCAGN02390 Retifanlimab | 0 | 4 |
INCAGN02390 | INCAGN02390 | 0 | 1 |